Stay updated with breaking news from David Epstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43
The drugmaker would pay $229 a share in cash for the biotech cancer specialist
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Washington-headquartered Seagen expects to make around $2.2bn in revenue this year, while Pfizer cements its position in oncology.
WASHINGTON: US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.Pfizer is offering...